Paul B Cleveland Insider Trading $ADVM Adverum Biotechnologies, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul B Cleveland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul B Cleveland. Paul B Cleveland is Director in SANGAMO BIOSCIENCES INC ($SGMO) and EVP, Corp. Development and CFO in AFFYMAX INC ($AFFY) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Interim President and CEO in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Chief Executive Officer in Adverum Biotechnologies, Inc. ($AAVL) and Director in Adverum Biotechnologies, Inc. ($ADVM) and President and CEO in Adverum Biotechnologies, Inc. ($AAVL).
Paul B Cleveland in Adverum Biotechnologies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul B Cleveland: Director, Chief Executive Officer, President and CEO
Holdings: 22,727 shares
Latest Transaction: Jun 15 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul B Cleveland in Adverum Biotechnologies, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, AFFY, ALDR, SGMO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2018 | ADVM | Adverum Biotechnol ... | Cleveland Paul B | Director | Option Exercise | A | 6.25 | 35,000 | 218,750 | 35,000 | |
| Jun 14 2017 | ADVM | Adverum Biotechnol ... | Cleveland Paul B | Chief Executive Off ... | Option Exercise | A | 2.75 | 33,602 | 92,406 | 33,602 | |
| Jun 14 2017 | ADVM | Adverum Biotechnol ... | Cleveland Paul B | Chief Executive Off ... | Grant | A | 0.00 | 22,727 | 0 | 22,727 | 0 to 22.7 K |
| May 13 2016 | AAVL | Adverum Biotechnol ... | Cleveland Paul B | Chief Executive Off ... | Option Exercise | A | 4.14 | 381,000 | 1,577,340 | 381,000 | |
| Dec 11 2015 | AAVL | Adverum Biotechnol ... | Cleveland Paul B | President and CEO | Option Exercise | A | 9.04 | 910,000 | 8,226,400 | 910,000 |
Page: 1